Knight Therapeutics (TSE: GUD)

Knight Therapeutics is a corporation based in Montreal, Canada. Established in 2013, the firm is a publicly, specialty pharmaceutical company focused on acquiring, in-licensing, out-licensing, marketing, and distributing innovative prescription pharmaceuticals, consumer health products, and medical devices in Canada and select international markets. The assets of the company are governed by the board of directors.